ARCHIVES

Richard Pazdur’s Comments to ODAC

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014